Antipsychotic drugs and risk of type 2 diabetes: an evidence-based approach

Human Psychopharmacology
Cesario BellantuonoPietro Donda

Abstract

To review studies conducted to evaluate the risk of type 2 diabetes in patients treated with different antipsychotic drugs (AP). a MEDLINE search (January 1985-February 2003) was conducted to establish the potential relationship between the exposure to AP (conventional and second generation) and the development of type 2 diabetes. Studies were classified according to their experimental design as prospective and retrospective (incidence and prevalence based). Twenty-one studies were selected: nine prospective and eleven retrospective. Patients with schizophrenia treated with different AP have an increased risk of developing type 2 diabetes compared with the general population. The data so far available, however, do not establish whether the increasing risk of developing diabetes is a function of the schizophrenia itself or is induced by the antipsychotic treatment. A number of methodological flaws in the study design and data collection do not allow conclusions to be drawn on the risk between patients treated with conventional drugs versus those treated with new ones.

References

Nov 18, 1989·Lancet·G O Finney
Jan 1, 1968·The American Journal of Psychiatry·E Thonnard-Neumann
Aug 1, 1968·The American Journal of Psychiatry·L Schwarz, R Munoz
Jan 1, 1996·Comprehensive Psychiatry·S MukherjeeP L Scapicchio
Apr 23, 1999·Lancet·T Walley, A Mantgani
Jun 1, 2000·The American Journal of Psychiatry·D C HendersonD C Goff
Nov 22, 2000·Schizophrenia Bulletin·L DixonA Lehman
Mar 10, 2001·The Journal of Clinical Psychiatry·A PredaM B Bowers
Dec 19, 2001·The American Journal of Medicine·E KollerG Dubitsky
Apr 2, 2002·The American Journal of Psychiatry·Michael J SernyakRobert Rosenheck
Apr 3, 2002·Archives of General Psychiatry·John W NewcomerGregg Selke
May 15, 2002·Journal of Clinical Psychopharmacology·Philip S WangJerry Avorn
Jul 20, 2002·Pharmacotherapy·Elizabeth A Koller, P Murali Doraiswamy
Oct 5, 2002·The Journal of Clinical Psychiatry·Cynthia J KornegayHershel Jick
Oct 31, 2002·Human Psychopharmacology·Beang-Jin Chae, Byung-Jo Kang
Nov 6, 2002·The Journal of Clinical Psychiatry·Donna A WirshingWilliam C Wirshing
Nov 28, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Karin HedenmalmOlav Spigset
Jan 14, 2003·The Journal of Clinical Psychiatry·J Jaime CaroKimberly Robinson
Feb 4, 2003·The American Journal of Psychiatry·Martina C M RyanJogin H Thakore
Feb 4, 2003·The American Journal of Psychiatry·Jean-Pierre LindenmayerJeffrey A Lieberman
Mar 26, 2003·Journal of Clinical Epidemiology·John B BuseLois Jovanovic
Jun 25, 2003·Pharmacotherapy·Elizabeth A KollerBruce S Schneider
Jul 18, 2003·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Mythily SubramaniamElaine Pek
Apr 1, 1955·The Journal of Mental Science·F B CHARATAN, N G BARTLETT
Dec 30, 2003·Human Psychopharmacology·Timothy G Dinan, Dora Kohen
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Apr 2, 2004·The British Journal of Psychiatry. Supplement·Dora Kohen
Apr 2, 2004·The British Journal of Psychiatry. Supplement·Chris Bushe, Richard Holt
Apr 2, 2004·The British Journal of Psychiatry. Supplement·Peter M Haddad
Apr 2, 2004·The British Journal of Psychiatry. Supplement·UNKNOWN Expert Group
Aug 5, 2004·The Journal of Clinical Psychiatry·Elizabeth A KollerBruce S Schneider

❮ Previous
Next ❯

Citations

Feb 26, 2008·European Journal of Pharmacology·Mohammad K MohammadYasser Bustanji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
T Wetterling
The American Journal of Psychiatry
Daisuke YasuharaAkio Inui
The American Journal of Psychiatry
C L Budman, A I Gayer
The British Journal of Psychiatry. Supplement
Chris Bushe, Richard Holt
© 2021 Meta ULC. All rights reserved